Knowledge and implementation of cardiovascular risk clinical practice guidelines by general practitioners and specialists;Conocimiento y aplicación de las guías de práctica clínica sobre riesgo cardiovascular en las consultas generales y especializadas

Revista Espanola de Cardiologia

Volumn 59, Issue 8, 2006, Pages 801-806

  González Juanatey, José R ^a   Alegría Ezquerra, Eduardo ^b   Aznar Costa, Joaquín ^c   Bertomeu Martínez, Vicente ^d   Franch Nadal, Josep ^e   Palma Gámiz, José L ^f  

^a Instituto de Salud Carlos III   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c Hospital Provincial de Nuestra Señora de Gracia   (Spain)

^d HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^e Centro de Atención Primaria Raval Nord   (Spain)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Cardiovascular prevention; Clinical practice guidelines; Coronary disease; Diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL PRACTICE; CONTROLLED STUDY; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH PRACTITIONER; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PROFESSIONAL KNOWLEDGE; RISK FACTOR;

EID: 33749648815     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13091884     Document Type: Article

References (38)

1. Mas JL. Atherothrombosis: management of patients at risk. Int J Clin Pract. 2005:59:407-14.
2. Abrams J. Chronic stable angina. N Engl J Med. 2005;352:2524-33.
3. Banegas JP, Segura J, Ruilope LM, Luque M, García-Robles R, Campo C, et al, for the CLUE Study Group Investigators. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Hypertension. 2004;43:1338-44.
4. González-Juanatey JR, Alegría E, García-Acuña JM, González-Maqueda I, Lozano JV. Impacto de la diabetes en las enfermedades cardíacas en España. Estudio Cardiotens 1999. Med Clin (Barc). 2001;116:686-91.
5. Álvarez-Sala LA, Suarez C, Mantilla T, Franch J, Ruilope LM, Banegas JR, et al. Estudio PREVENCAT: control del riesgo cardiovascular en atención primaria. Med Clin (Barc). 2005;124:406-10.
6. Van Ganse E, Laforest L, Alemao E, Davies G, Gutkin S, Yin D. Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study. Curr Med Res Opin. 2005;21:1389-99.
7. Davidson MH, Maki KC, Pearson TA, Pasternak RC, Deedwania PC, McKenney JM, et al. Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations. Am J Cardiol. 2005;96:556-63.
8. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005;28 Suppl 1:S4-36.
9. Guidelines Committee. 2003 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hipertension. J Hypertens. 2003;21:1011-53.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. JAMA. 2003;289:2560-72.
11. González-Juanatey JR, Mazón P, Soria F, Barrios V, Rodríguez Padial L, Bertomeu V. Actualización (2003) de las Guías de Práctica Clínica de la Sociedad Española de Cardiología en hipertensión arterial. Rev Esp Cardiol. 2003;56:487-97.
12. Ministerio de Sanidad y Consumo. Plan integral de la Cardiopatía Isquémica en España. Disponible en: www.msc.es /planesIntegrales/ PICI
13. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DM, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-39.
14. Brotons C, Royo-Bordonada MA, Álvarez-Sala L, Armario P, Artigao R, Conthe P, et al, Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC). Adaptación española de la Guía Europea de Prevención Cardiovascular. Aten Primaria. 2004;34:427-32.
15. Marin R, De la Sierra A, Armario P, Campo C, Banegas JR, Gorostidi M; Sociedad Española de Hypertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA). Guía sobre el diagnóstico y tratamiento de la hipertensión arterial en España 2005. Med Clin (Barc). 2005;125:24-34.
16. Grupo de trabajo en HTA de la SEMFyC. Automedición de la presión arterial en atención primaria (II). Aten Primaria. 2003;31:606-12.
17. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina -summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 2003;41:159-68.
18. Grup d'Estudis de la Diabetes a l'Atenció Primaria de Salut. Disponible en: www.scmfyc.org/php
19. Sociedad Española de Medicina Familiar y Comunitaria. Manual de Prevención en Atención Primaria. Disponible en: www.semfyc.es/es/ actividades/publicaciones
20. Cordero A, Moreno J, Alegría E. Hipertensión arterial y síndrome metabólico. Rev Esp Cardiol. 2006;5 Suppl D:38-45.
21. Baena JM, Del Val JL, Tomás J, Martínez JL, Martín R, González I, et al. Epidemiología de las enfermedades cardiovasculares y factores de riesgo en atención primaria. Rev Esp Cardiol. 2005; 58:367-73.
22. Cristóbal J, Lago F, De la Fuente J, González-Juanatey JR, Vázquez P, Vila M. Ecuación de Framingham de Wilson y ecuación de REGICOR. Estudio comparativo. Rev Esp Cardiol. 2005; 58: 910-5.
23. García L, Santos I, Sánchez PL, Mora MC, Arganda J, Rodríguez MT. Efectividad de una intervención de mejora de calidad en la reducción del riesgo cardiovascular en pacientes hipertensos. Rev Esp Cardiol. 2004;57:644-51.
24. Palma-Gámiz JL, Hernández A, Bertomeu V, González-Juanatey JR, López V, Calderón A, et al. La diabetes mellitus en la práctica de la cardiología en España. Encuesta del Grupo de Trabajo de Corazón y Diabetes sobre la importancia de la diabetes mellitus en relación con las enfermedades cardiovasculares. Rev Esp Cardiol. 2004;57:661-6.
25. Pyorala K, Lehto S, De Bacquer D, De Sutter J, Sans S, Keil U, for the EUROASPIRE I and EUROASPIRE II Groups. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I and II surveys. Diabetologia. 2004;47:1257-65.
26. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, for the REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180-9.
27. García FM, García A, Montero MJ; grupo de Información sobre Medicamentos de la Dirección General de Asistencia Sanitaria de Sacyl. Objetivos de presión arterial en el diabético: evaluación crítica. Med Clin (Barc). 2004;122:584-91.
28. Spranger CB, Ries AJ, Berge CA, Radford NB, Victor RG. Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med. 2004;117:14-8.
29. Komajda M, Lapuerta P, Hermans N, González-Juanatey JR, Van Veldhuisen DJ, Erdmann E, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J. 2005;26:653-9.
30. Van Ganse E, Souchet T, Laforest L, Moulin P, Bertrand M, Le Jeunne P, et al. Long-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: an observational study. Atherosclerosis. 2006;185:58-64.
31. Kirk JK, Poirier JE, Mattox MG, Thomas PM, Michielutte R. Compliance with national guidelines in patients with diabetes in a family practice clinic. Pharmacotherapy. 2002;22:1541-6.
32. Bourgault C, Davignon J, Fodor G, Gagne C, Gaudet D, Genest J, et al. Statin therapy in Canadian patients with hypercholesterolemia: The Canadian Lipid Study-Observational (CALIPSO). Can J Cardiol. 2005;21:187-93.
33. Tierney WM, Overhage JM, Murray MD, Harris LE, Zhou XH, Eckert GJ, et al. Effects of computerized guidelines for managing heart disease in primary care. J Gen Intern Med. 2004;19:967-76.
34. LaBresh KA, Ellrodt AG, Glicklich R, Liljestrand J, Peto R. Get with the guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med. 2004;164:203-9.
35. Stein EA, Sniderman A, Laskarzewski P. Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B. Am J Cardiol. 2005;96:36-43.
36. Milani RV. Reaching for aggressive blood pressure goals: role of angiotensin receptor blockade in combination therapy. Am J Manag Care. 2005;11 Suppl 7:S220-7.
37. McInnes GT. How important is optimal blood pressure control? Clin Ther. 2004;26 Suppl A:A3-11.
38. Bakris GL. The importance of blood pressure control in the patient with diabetes. Am J Med. 2004;116 Suppl 5A:30S-8.